Teething-colic Pellet
NDC Package 55714-1730-1
Package Information
Teething-colic (chamomilla, valeriana officinalis, aconitum napellus, apis mellifica, baptisia tinctoria, belladonna, borax, bryonia, calcarea carbonica, calcarea phosphorica, chamomilla, chelidonium majus, coffea cruda, collinsonia canadensis, colocynthis, kreosotum, magnesia phosphorica, nux vomica, podophyllum peltatum, rheum, scutellaria lateriflora, silicea, terebinthina, zingiber officinale) pellets is formuated for associated symptoms such as inconsolable crying, painful and swollen gums, sleeplessness and other related symptoms. This formulation utilizes a pellet delivery system. Marketed by Newton Laboratories, Inc., this product is identified by NDC 55714-1730.
Identification & Billing
Clinical Specifications
- ACONITUM NAPELLUS 15 [hp_X]/g
- APIS MELLIFERA 15 [hp_X]/g
- ARABICA COFFEE BEAN 15 [hp_X]/g
- ATROPA BELLADONNA 15 [hp_X]/g
- BAPTISIA TINCTORIA ROOT 15 [hp_X]/g
- BRYONIA ALBA ROOT 15 [hp_X]/g
- CHELIDONIUM MAJUS 15 [hp_X]/g
- CITRULLUS COLOCYNTHIS FRUIT PULP 15 [hp_X]/g
- COLLINSONIA CANADENSIS ROOT 15 [hp_X]/g
- GINGER 15 [hp_X]/g
- MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE 15 [hp_X]/g
- MATRICARIA CHAMOMILLA 15 [hp_X]/g
- OYSTER SHELL CALCIUM CARBONATE, CRUDE 15 [hp_X]/g
- PODOPHYLLUM 15 [hp_X]/g
- RHEUM OFFICINALE ROOT 15 [hp_X]/g
- SCUTELLARIA LATERIFLORA WHOLE 15 [hp_X]/g
- SILICON DIOXIDE 15 [hp_X]/g
- SODIUM BORATE 15 [hp_X]/g
- STRYCHNOS NUX-VOMICA SEED 15 [hp_X]/g
- TRIBASIC CALCIUM PHOSPHATE 15 [hp_X]/g
- TURPENTINE OIL 15 [hp_X]/g
- VALERIAN 6 [hp_X]/g
- WOOD CREOSOTE 15 [hp_X]/g
- Allergens - [CS]
- Allergens - [CS]
- Bee Venoms - [CS]
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Food Additives - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Seed Storage Proteins - [CS]
- Standardized Insect Venom Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 55714 - Newton Laboratories, Inc.
- 55714-1730 - Teething-colic
- 55714-1730-1 - 28 g in 1 BOTTLE, GLASS
- 55714-1730 - Teething-colic
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 55714-1730-1 identifies a specific commercial package of 28 g in 1 bottle, glass of Teething-colic, a human over the counter drug labeled by Newton Laboratories, Inc.. This pellet is formulated for oral use and contains aconitum napellus; apis mellifera; arabica coffee bean; atropa belladonna; baptisia tinctoria root; bryonia alba root; chelidonium majus; citrullus colocynthis fruit pulp; collinsonia canadensis root; ginger; magnesium phosphate, dibasic trihydrate; matricaria chamomilla; oyster shell calcium carbonate, crude; podophyllum; rheum officinale root; scutellaria lateriflora whole; silicon dioxide; sodium borate; strychnos nux-vomica seed; tribasic calcium phosphate; turpentine oil; valerian; wood creosote as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Newton Laboratories, Inc. on January 01, 2019. The current certification is valid through December 31, 2026.
How is this Newton Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 55714173001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.